Patent Assignment
Reel/Frame 052455/0436
Assignment of Assignor's Interest
Recorded: 2020-04-21
Pages: 7
Assignor
ARISTA, LUCA
Executed: 2020-04-15
Assignee
BLACK DIAMOND THERAPEUTICS, INC.
139 MAIN STREET, SUITE 301, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(3)
Tyrosine Kinase Inhibitor Compositions, Methods of Making and Methods of Use
Patent:
11,034,672 →
Application:
16/851,767 →
Publication:
US 2021/0163447
PCT:
PCT/US2019/052784 ↗
Tyrosine Kinase Inhibitor Compositions, Methods of Making and Methods of Use
Application:
62/736,293 →
Tyrosine Kinase Inhibitor Compositions, Methods of Making and Methods of Use
Application:
62/903,592 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 1, 2018
From: EPSTEIN, DAVID M.; BUCK, ELIZABETH
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 047386/0225 →
Assignment of Assignor's Interest
Nov 2, 2018
From: TRAINOR, GEORGE; O'CONNOR, MATTHEW
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 047398/0878 →
Assignment of Assignor's Interest
Nov 6, 2018
From: FLOHR, ALEXANDER; MAYWEG, ALEXANDER
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 047426/0586 →
Assignment of Assignor's Interest
Nov 7, 2019
From: FLOHR, ALEXANDER; MAYWEG, ALEXANDER; TRAINOR, GEORGE; EPSTEIN, DAVID M.
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 050940/0983 →
Assignment of Assignor's Interest
May 21, 2020
From: FLOHR, ALEXANDER; MAYWEG, ALEXANDER; TRAINOR, GEORGE; EPSTEIN, DAVID M.
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 052727/0796 →